SmartCatch

Markets portable products for liquid biopsy of circulating tumour cells (CTCs), to make this procedure standardized, accessible and used in routine clinical practice. This liquid biopsy approach offers better representativeness of solid tumours by enabling real-time monitoring, while personalizing care. These microfiltration devices isolate CTCs directly from whole blood, without the need for pre-analytical steps, facilitating diagnosis, monitoring and personalized treatment.